|Bid||81.92 x 1000|
|Ask||81.94 x 800|
|Day's Range||81.23 - 81.96|
|52 Week Range||71.83 - 103.00|
|Beta (3Y Monthly)||1.43|
|PE Ratio (TTM)||35.99|
|Earnings Date||Oct 30, 2019|
|Forward Dividend & Yield||0.28 (0.34%)|
|1y Target Est||99.08|
Billionaire hedge fund managers such as David Abrams, Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses, and financial services hubs, while the nearly unlimited research abilities of […]
PerkinElmer (PKI) is gaining steadily from the core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.
PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that on Wednesday, October 30, 2019, after market close, the Company will release third quarter 2019 results.
The Freiberg Instruments' Magnettech EPR business acquisition is expected to boost Bruker's (BRKR) BioSpin business by complementing its existing range of EPR offerings.
In accordance with the terms of the indenture governing the 2021 Notes (the “Indenture”), the 2021 Notes will be redeemed on October 13, 2019 (the “Redemption Date”), at a redemption price equal to the greater of (i) 100% of the principal amount of the 2021 Notes to be redeemed and (ii) the sum of the present values of the remaining scheduled payments of principal and interest, discounted to the Redemption Date on a semi-annual basis at the Treasury Rate (as defined in the Indenture), plus 45 basis points. The redemption price will also include, in each case, accrued and unpaid interest on the 2021 Notes to, but excluding, the Redemption Date.
PerkinElmer, Inc. (PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $850 million aggregate principal amount of 3.300% Senior Notes due 2029 at an issue price of 99.670% of the principal amount. PerkinElmer plans to use approximately $770 million of the net proceeds of the offering to repay all amounts outstanding under its senior unsecured revolving credit facility (the “Credit Facility”). It plans to replace the Credit Facility with a new $1.0 billion, five-year senior unsecured revolving credit facility with Bank of America, N.A. as administrative agent.
Moody's Investors Service ("Moody's") assigned a Baa3 rating to the proposed offering of senior unsecured 10-year notes of PerkinElmer, Inc. ("PerkinElmer"). There are no changes to Moody's existing ratings of PerkinElmer including the Baa3 senior unsecured long-term rating. The proposed offering slightly increases PerkinElmer's financial leverage to just above 4x, which is high for the Baa3 rating.
PerkinElmer (PKI) is gaining steadily from core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.
PerkinElmer (PKI) delivered earnings and revenue surprises of -0.99% and -1.06%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, NY / ACCESSWIRE / July 29, 2019 / PerkinElmer, Inc. (United States) (NYSE: PKI ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 29, 2019 at ...
Top-line growth and robust performance at Diagnostics segment are likely to aid PerkinElmer's (PKI) Q2 earnings. However, forex is likely to be a dampener.